Previous 10 | Next 10 |
home / stock / lxxgf / lxxgf news
BEVERLY, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today announced the appointme...
BEVERLY, Mass., March 24, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today announced the appointme...
BEVERLY, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, today announces that it has r...
Seattle, Washington--(Newsfile Corp. - March 9, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing how LexaGene Holdings Inc. (OTCQB: LXXGF) (TSXV: LXG) is focused on...
BEVERLY, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced to...
Phoenix, Arizona--(Newsfile Corp. - January 28, 2020) - The Stock Day Podcast welcomed LexaGene Holdings Inc. (OTCQB: LXXGF) ("the Company"), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diagn...
BEVERLY, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a biotechnology company that develops genetic analyzers for the rapid detection of pathogens and other molecular mar...
BEVERLY, Mass., Jan. 21, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today it has expande...
Throughout the course of 2019, investors in the medical device space were interested in a variety of stories on the growth and catalysts available to companies in this sector. From US Food and Drug Administration (FDA) news to global expansion and updates on the development process for medic...
Phoenix, Arizona--(Newsfile Corp. - November 18, 2019) - The Stock Day Podcast welcomed LexaGene Holdings Inc. (OTCQB: LXXGF) ("the Company"), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diag...
News, Short Squeeze, Breakout and More Instantly...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...